A SOLE THROMBOPROPHYLACTIC IN PRESCRIPTION OF POSTOPERATIVE ORTHOPEDIC PATIENTS – A REVIEW

Main Article Content

Veerapandian Durga
Vaishnavi Devi C

Abstract

Background: Venous thromboembolism(VTE) is one of the most well-known and feared sequelae of orthopaedic surgery. VTE is relatively common after arthroplasty, prophylaxis has been prescribed. The frequency of postoperative thromboembolic events increased in the absence of primary prevention. Following operations, immobilisation of a lower limb that restricts calf muscle contraction has been shown to be a key risk factor for VTE. VTE is the most frequent source of readmission in orthopaedic patients who have undergone major procedures. It should be emphasized that the best mechanical method for preventing VTE is early walking. Medication for VTE prophylaxis is prescribed more often than mechanical prophylaxis. After major orthopaedic surgery, anticoagulant treatment is essential for reducing morbidity and death. Following hospital discharge, prophylactic drug therapy aims to reduce the morbidity and mortality episodes associated with DVT and PE occurrences. Aspirin use for prevention of VTE following THA and TKA has gained popularity, especially among orthopaedic surgeons due to a minimal risk of postoperative haemorrhage, it also reduces the incidence of recurrent DVTs. Conclusion: Due to its low cost and easy administration without the requirement for regular blood testing, aspirin thromboprophylaxis following knee surgery appears promising. Aspirin saved more QALYs and was cost-effective. Aspirin was demonstrated to have a higher VTE prophylaxis profile than other medications with a time-related association to early mobilisation, healthier patients and medication compliance.

Article Details

How to Cite
1.
Durga V, C VD. A SOLE THROMBOPROPHYLACTIC IN PRESCRIPTION OF POSTOPERATIVE ORTHOPEDIC PATIENTS – A REVIEW. IJPBR [Internet]. 4Apr.2023 [cited 21Feb.2024];11(01). Available from: http://www.ijpbr.in/index.php/IJPBR/article/view/1033
Section
Review Article

References

1. Yi YH, Gong S, Gong TL, Zhou LY, Hu C, Xu WH. New Oral Anticoagulants for Venous Thromboembolism Prophylaxis in Total Hip and Knee Arthroplasty: A Systematic Review and Network Meta-Analysis. Front Pharmacol. 2022 Jan 17;12:775126.
2. Pretorius J, Nemat N, Azeem I, Shaju T, Nadeem S, Hammad Y. Is aspirin still relevant as a single pharmacological agent for venous thromboembolism prophylaxis post hip and knee arthroplasty surgery: A retrospective review. SICOT J. 2022;8:28.
3. Azboy I, Barrack R, Thomas AM, Haddad FS, Parvizi J. Aspirin and the prevention of venous thromboembolism following total joint arthroplasty: commonly asked questions. Bone Joint J. 2017 Nov;99-B(11):1420-1430.
4. Metcalf KB, Du JY, Ochenjele G. Does Aspirin Provide Adequate Chemoprophylaxis for Venous Thromboembolic Events in Operative Pelvic and Acetabular Fractures? Iowa Orthop J. 2022 Jun;42(1):83-88.
5. Zambelli R, Bastos M, Rezende SM. Prophylaxis of Venous Thromboembolism in Ankle and Foot Surgeries. Rev Bras Ortop (Sao Paulo). 2020 Sep 25;56(6):697-704.
6. Manfredi VM, Machado MB, Barbato NG, Takata ET, Dobashi ET. Effectiveness of Deep Venous Thrombosis Prevention in Total Hip Arthroplasty. Acta Ortop Bras. 2021 Nov-Dec;29(6):293-296.
7. Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev. 2018 Apr 27;3(4):136-148.
8. Bala A, Huddleston JI 3rd, Goodman SB, Maloney WJ, Amanatullah DF. Venous Thromboembolism Prophylaxis After TKA: Aspirin, Warfarin, Enoxaparin, or Factor Xa Inhibitors? Clin Orthop Relat Res. 2017 Sep;475(9):2205-2213.
9. Lu X, Lin J. Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2018 Sep 8;19(1):322.
10. Degli Esposti L, Didoni G, Simon T, Buda S, Sangiorgi D, Degli Esposti E. Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study. Clinicoecon Outcomes Res. 2013;5:1-7.
11. Marrannes S, Victor K, Arnout N, De Backer T, Victor J, Tampere T. Prevention of venous thromboembolism with aspirin following knee surgery: A systematic review and meta-analysis. EFORT Open Rev. 2021 Oct 19;6(10):892-904.
12. Goel R, Fleischman AN, Tan T, Sterbis E, Huang R, Higuera C, Parvizi J, Rothman RH. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin versus warfarin. Bone Joint J. 2018 Jan;100-B(1 Supple A):68-75.
13. Sharda AV, Fatovic K, Bauer KA. Aspirin thromboprophylaxis in joint replacement surgery. Res Pract Thromb Haemost. 2022 Jan 24;6(1):e12649.
14. Chu JN, Maselli J, Auerbach AD, Fang MC. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty. Thromb Res. 2017 Jul;155:65-71.
15. Etscheidt J, Shahien A, Gainey M, Kronenfeld D, Niu R, Freccero D, Smith E. Review of Therapeutic Options for the Prevention of VTE in Total Joint Arthroplasty. Geriatrics (Basel). 2020 Mar 18;5(1):18.
16. Santana DC, Emara AK, Orr MN, Klika AK, Higuera CA, Krebs VE, Molloy RM, Piuzzi NS. An Update on Venous Thromboembolism Rates and Prophylaxis in Hip and Knee Arthroplasty in 2020. Medicina (Kaunas). 2020 Aug 19;56(9):416.